AI Summary Saxenda (liraglutide) is a once-daily injection used for chronic weight management in adults with obesity or overweight with a weight-related condition.
Medically Reviewed.
Saxenda (liraglutide) is a prescription GLP-1 receptor agonist approved for chronic weight management in adults with obesity, or in adults who are overweight with at least one weight-related medical condition, such as high blood pressure, high cholesterol, or type 2 diabetes. It contains the same active ingredient as Victoza but is used at a higher dose and is indicated for weight management rather than type 2 diabetes treatment. Because obesity and related metabolic risk factors drive MASLD and MASH, some healthcare providers explore or prescribe Saxenda for eligible patients to support sustained weight loss, though it is not a direct liver treatment. Treatment decisions should always be individualized and guided by a healthcare professional.
This page covers Saxenda's role in MASLD and MASH management — how it works, who may be eligible, benefits, side effects, and monitoring. You can also connect with a liver specialist near you for personalized guidance on whether Saxenda fits your care plan.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
ABOUT SAXENDA TREATMENT
Saxenda is a prescription medicine that contains liraglutide, a type of medication known as a GLP-1 receptor agonist. It mimics a natural hormone that helps regulate appetite, food intake, and energy balance, slowing stomach emptying and helping you feel full longer.
Saxenda is approved for chronic weight management in adults with obesity, or in adults who are overweight with at least one weight-related medical condition, such as high blood pressure, high cholesterol, or type 2 diabetes. It contains the same active ingredient as Victoza but is used at a higher dose and is indicated for weight management rather than type 2 diabetes treatment.
Because obesity and related metabolic risk factors drive MASLD and MASH, some healthcare providers prescribe Saxenda to support sustained weight loss as part of a broader liver care plan, even though it is not a direct liver treatment. It is typically used alongside dietary changes, physical activity, and regular monitoring by your healthcare provider, such as Liver Function Tests (LFTs) or imaging.
WHO SAXENDA MAY BE SUITABLE FOR
Eligibility for Saxenda depends on the medication's approved use, your diagnosis, and your individual health needs. Saxenda is approved for adults with obesity, or adults who are overweight with at least one weight-related medical condition, such as high blood pressure, high cholesterol, or type 2 diabetes. It may be considered for people who meet these criteria and who also have MASLD or MASH linked to obesity or other metabolic risk factors.
Your medical history, current health status, liver condition, and any other medications you take all factor into whether Saxenda is an appropriate option for you.
Because every patient's health profile is different, there is no one-size-fits-all answer to who should take Saxenda. Treatment decisions are individualized and should be made by a qualified healthcare professional after a full assessment of your liver condition, metabolic health, and treatment goals. Your doctor will weigh the potential benefits against any risks before determining whether Saxenda fits safely into your broader care plan.
ELIGIBILITY OVERVIEW
Saxenda may be considered for adults with the following conditions, risk factors, or treatment goals:
Before recommending Saxenda, healthcare providers evaluate several factors to determine whether it is an appropriate option, including:
HOW SAXENDA CAN HELP YOUR LIVER
Saxenda activates GLP-1 receptors in the brain and digestive system, reducing appetite and hunger signals, increasing feelings of fullness after eating, and slowing gastric emptying to reduce calorie intake. Together, these effects help regulate energy balance and food intake.
These actions target one of the central metabolic drivers behind MASLD and MASH: excess body weight. As body weight decreases, fat tends to build up less in liver cells, and the inflammation that drives disease progression may ease.
For patients with MASLD or MASH, sustained weight loss with Saxenda can support treatment goals such as reduced liver fat, improved metabolic risk factors, and a lower risk of disease progression. Saxenda is not used on its own — providers pair it with a reduced-calorie, nutritionally balanced diet, regular physical activity, and regular monitoring, such as Liver Function Tests (LFTs), to support these outcomes.
LIVER BENEFITS
Excess body weight is a major contributor to fat buildup in liver cells. By supporting sustained weight loss, Saxenda addresses this underlying driver and may help reduce the amount of fat stored in the liver.
Obesity is closely tied to insulin resistance and other metabolic risk factors that drive MASLD and MASH. Saxenda's weight-loss effect may help improve these obesity-related metabolic risk factors.
Weight loss is one of the most effective ways to improve fatty liver disease. Saxenda reduces appetite and hunger signals and slows gastric emptying, supporting sustained weight loss when combined with a reduced-calorie diet and exercise.
MASLD can progress to MASH, liver fibrosis, or cirrhosis over time. Achieving and maintaining meaningful weight loss may help lower risk factors linked to disease progression, although individual outcomes vary.
Saxenda supports liver health mainly by helping people achieve and sustain clinically meaningful weight loss, which may help people with MASLD or MASH. It should only be started and monitored under the guidance of a qualified healthcare professional.
TREATMENT PROCESS
Saxenda is supplied in a prefilled injection pen. Check the solution before use to make sure it is clear and colorless. If it looks cloudy, discolored, or contains particles, do not use it — contact your pharmacist or healthcare provider instead.
Saxenda may be injected into the abdomen, thigh, or upper arm. Rotate injection sites regularly to help avoid skin irritation.
The usual starting dose is 0.6 mg once daily. The dose is increased weekly by 0.6 mg until the maintenance dose of 3.0 mg once daily is reached. Your healthcare provider determines the right dose and any adjustments based on how you respond.
Clean the injection site with an alcohol swab and follow the instructions provided with the injection pen. Always use Saxenda exactly as your healthcare provider directs.
Saxenda is intended for long-term chronic weight management and is typically continued as long as it remains effective and well tolerated. Ongoing treatment, together with lifestyle modifications, helps support sustained weight loss and weight maintenance.
Store unused pens in the refrigerator. After first use, pens may be stored according to manufacturer recommendations and protected from excessive heat and light.
Regular monitoring of body weight and treatment response is recommended. For people using Saxenda to support MASLD or MASH management, providers may also monitor liver health measures, such as Liver Function Tests (LFTs), alongside routine follow-up. Report any side effects or unusual symptoms to your healthcare provider.
BENEFITS AND SAFETY
Saxenda (liraglutide) may support people with MASLD and MASH by helping them achieve and sustain clinically meaningful weight loss, which addresses one of the central metabolic drivers of fat buildup and inflammation in the liver. By reducing appetite and hunger signals and slowing gastric emptying, it may contribute to reduced liver fat and improved obesity-related metabolic risk factors over time. The extent of these benefits varies from person to person, depending on their liver condition, overall metabolic health, treatment plan, and how their body responds to therapy. Saxenda is not a stand-alone liver treatment — it works best as part of a comprehensive weight management program that combines the medication with a reduced-calorie, nutritionally balanced diet, regular physical activity, and ongoing monitoring like Liver Function Tests (LFTs) or imaging.
As with any medication, Saxenda may cause side effects, ranging from mild digestive symptoms to less common reactions. Your healthcare provider will assess whether Saxenda is a suitable option for you and will monitor your treatment response throughout therapy, adjusting the dose or overall care plan as needed to balance potential benefits against any risks.
BENEFITS
Saxenda supports clinically meaningful and sustained weight reduction by reducing appetite and hunger signals and slowing gastric emptying, when combined with a reduced-calorie diet and exercise. Because excess weight drives fat buildup in the liver, this benefit may help reduce liver fat in people with MASLD or MASH.
Saxenda reduces hunger and food cravings, helping people stick to a reduced-calorie eating plan as part of a comprehensive weight management program.
By supporting sustained weight loss, Saxenda may improve obesity-related metabolic risk factors, such as insulin resistance, that are also central drivers of fat buildup and inflammation in the liver.
Saxenda's gradual weekly dose increase, from 0.6 mg up to the 3.0 mg maintenance dose, is designed to improve tolerability as the body adjusts to the medication.
These effects are often more noticeable when starting treatment or increasing the dose and may improve over time. Your healthcare provider will discuss the potential benefits and risks before treatment and provide ongoing support to ensure safe use.
SUPPORTING YOUR RESULTS
Saxenda should be used as part of a comprehensive weight management program. Lifestyle changes in nutrition, physical activity, and long-term healthy habits are essential alongside the medication.
These habits can support how your body responds to treatment and may help maximize weight loss and improve overall health outcomes.
Areas that may support treatment:
COMMON QUESTIONS
No. Saxenda is not a direct liver treatment for MASLD or MASH. It is approved for chronic weight management in adults with obesity, or in adults who are overweight with at least one weight-related condition. Because excess body weight is a central driver of fat buildup and inflammation in the liver, some healthcare providers prescribe Saxenda to support sustained weight loss as part of a broader liver care plan. Your provider will also look at your liver tests and imaging to decide what treatment fits you.
Liraglutide is a GLP-1 receptor agonist, a medicine that mimics a natural hormone in your body. That hormone helps regulate appetite, food intake, and energy balance. Liraglutide reduces appetite and hunger signals, helps you feel full after eating, and slows how quickly the stomach empties, which lowers calorie intake. It works best alongside a reduced-calorie diet and regular physical activity.
Saxenda and Victoza contain the same active ingredient, liraglutide, but they are used for different purposes. Saxenda is used at a higher dose, with a maintenance dose of 3.0 mg once daily, and is indicated for chronic weight management. Victoza is indicated for treating type 2 diabetes. Do not switch between them on your own. Your healthcare provider chooses the medicine and dose that match your health goals.
Saxenda may be considered for adults with obesity, or adults who are overweight with a weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes. Providers may also consider it when lifestyle changes alone have not produced enough weight loss and medical therapy is needed as part of a comprehensive weight management plan. Your provider will review your diagnosis, medical history, current medications, and test results before deciding whether it is a safe option for you.
Saxenda is injected under the skin once daily with a prefilled pen. You can inject into the abdomen, thigh, or upper arm, and you should rotate sites regularly. Treatment usually starts at 0.6 mg once daily. Your dose then increases weekly by 0.6 mg until it reaches the maintenance dose of 3.0 mg once daily. Before each use, check that the solution is clear and colorless, and clean the site with an alcohol swab. Always follow your provider's directions and the instructions that come with your pen.
The most common side effects affect the digestive system: nausea, vomiting, diarrhea, or constipation. Some people also have decreased appetite or abdominal discomfort and bloating. Injection site reactions are uncommon. These effects are often more noticeable when you start treatment or raise the dose, and they may improve over time. Tell your healthcare provider about any side effects or unusual symptoms so they can support you and adjust your care plan if needed.
Saxenda is intended for long-term chronic weight management. Providers typically continue it as long as it remains effective and well tolerated, so do not stop it without talking to your provider. It works best as part of a comprehensive program that includes a reduced-calorie, nutritionally balanced diet, regular physical activity, and long-term healthy habits. Expect regular check-ins to monitor your weight and treatment response. If you have MASLD or MASH, your provider may also track liver measures, such as Liver Function Tests (LFTs).
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
